Boutique consulting firm CAR-T Global, which specializes in the commercialization of cell and gene therapies, has raised $100K in new capital. Founded in 2021, the company works with both small and large organizations, assisting teams across commercial planning, medical affairs, and market access.
CAR-T Global also dedicates significant effort to improving access to transformative treatments, such as CAR-T therapies, in low- and middle-income countries. The firm operates as an international consulting organization, collaborating with partners across North America, Europe, Latin America, and Southeast Asia.















